Clinical Trials Logo

Clinical Trial Summary

Women's participation in sports at all levels has been increasing in recent decades. Many individual and team sports are at risk of anterior cruciate ligament (ACL) injury. This injury leads to a permanent or long-lasting interruption of sports practice and to significant medical and economic expenses. Women are recognized as being more at risk of anterior cruciate ligament injury with a risk 6 times higher than men. Hyperlaxity is a risk factor for anterior cruciate ligament injury, but the pathophysiological bases are little studied. Hormonal impregnation and certain periods of the menstrual cycle (ovulatory phase) are risk factors for anterior cruciate ligament injury. It therefore seems interesting to investigators to study the influence of hormonal impregnation on ligament laxity. To date no study has investigated such a relationship.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05177549
Study type Interventional
Source Centre Hospitalier Universitaire de Nice
Contact Christian ROUX
Phone 04 92 03 92 20
Email roux.c2@chu-nice.fr
Status Recruiting
Phase N/A
Start date June 8, 2022
Completion date February 15, 2025

See also
  Status Clinical Trial Phase
Completed NCT03747198 - Methylsulfonylmethane on Knee Laxity N/A
Completed NCT05763108 - Clinical Significance and Coexistence of Polymorphisms of Individual Collagen-coding Genes